The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kam, C. M.
Right arrow Articles by Powers, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kam, C. M.
Right arrow Articles by Powers, J. C.

The Journal of Immunology, Vol 149, Issue 1 163-168, Copyright © 1992 by American Association of Immunologists

ARTICLES

Substituted isocoumarins as inhibitors of complement serine proteases

CM Kam, TJ Oglesby, MK Pangburn, JE Volanakis and JC Powers
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta 30332.

Inhibition of complement proteins D, B, C2, C1s, C1r, I, and the catalytic fragments Bb and C2a by substituted isocoumarins was investigated. 3,4-Dichloroisocoumarin, a general serine protease inhibitor, inhibited factor D, C1r, and C1s moderately with second- order inhibition constants (kobs/[I]) of 40 to 190 M-1 s-1, but it did not inhibit C2, factor B, C2a, or Bb. The best inhibitor for factors D and B was 4-chloro-7-guanidino-3-methoxyisocoumarin with kobs/[I] values of 250 and 290 M-1 s-1, respectively. Most isocoumarins did not inhibit C2 or C2a; only 4-chloro-3-isothiureidoalkoxyisocoumarins were slightly inhibitory. 3-Alkoxy-4-chloro-7-guanidinoisocoumarins inhibited C1r and C1s moderately. The best inhibitor for C1r and C1s was 4-chloro-3-(3-isothiureidopropoxy)isocoumarin with kobs/[I] values of 6,600 and 130,000 M-1 s-1, respectively. Fifty amino acid or peptide thioesters containing Arg or other amino acids at the P1 site were tested as substrates of factor I, however none was hydrolyzed. Isocoumarins substituted with chloro and basic groups such as guanidino and isothiureidoalkoxy inhibited factor I activity with its natural substrate C3b, but kobs/[I] values were low. 4-Chloro-3-ethoxy-7- guanidinoisocoumarin inhibited activation of the alternative pathway and, to a lesser extent, of the classical pathway in serum. Several other substituted isocoumarins also inhibited cobra venom factor- initiated activation of the alternative pathway in serum.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. A. Tsiftsoglou and R. B. Sim
Human Complement Factor I Does Not Require Cofactors for Cleavage of Synthetic Substrates
J. Immunol., July 1, 2004; 173(1): 367 - 375.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Rawal and M. K. Pangburn
C5 Convertase of the Alternative Pathway of Complement. KINETIC ANALYSIS OF THE FREE AND SURFACE-BOUND FORMS OF THE ENZYME
J. Biol. Chem., July 3, 1998; 273(27): 16828 - 16835.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Kim, S. V. L. Narayana, and J. E. Volanakis
Crystal Structure of a Complement Factor D Mutant Expressing Enhanced Catalytic Activity
J. Biol. Chem., October 13, 1995; 270(41): 24399 - 24405.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.